Related Experiment Video
Updated: Apr 17, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Which place for metformin in the management of type 2 diabetes ?]
André Scheen1, Nicolas Paquot1
1Service de Diabétologie, Nutrition et Maladies métaboliques, CHU Liège, Belgique.
Abstract:
Metformin remains the first-line pharmacological agent for the treatment of type 2 diabetes. This clinical vignette first recalls the fundamental reasons supporting this recommendation. It then considers situations that may raise concerns, particularly in patients with renal disease and those with cardiovascular disease. Finally, several practical advises for a cautious use and an optimization of both tolerance and safety are outlined.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Oral Hypoglycemic Agents: Glinides

